FDA amended EUA for COVID bivalent mRNA technology booster (April 18th) (Pfzier-BioNTech & Moderna for original & BA4/BA5 clades); then CDC's ACIP advisory group met April 19th, 2023

by Paul Alexander

VRBPAC (Jan 26th 2023); for this 'simplified' approach Dr. Wiseman below outlines the FAILURE & risk of the FDA & CDC decisions given no supporting data, omission of VAERS data on stroke signals

Dr. David Weisman (excellent scholarship) is lead scientist here:

ACIP April 19 2023: Bivalent primary series dosing with no directly supportive data and in the face of ever more resistant variants. Ischemic stroke signal in VAERS ignored. Written remarks CDC-2023-0028